Therefore, in this study we chose to generate patient-specific human iPSCs carrying c.512A>G mutation, which could be used as an iPSC-based disease model for pursuing how disruption of ELMOD3 causes hearing loss. This evidence concerns the gene ELMOD3 and hearing loss disorder.